Work

Milds Matter—Feasibility of Emicizumab Prophylaxis in Mild Hemophilia

Year: 2026

Type: article

Abstract: The data that support the findings of this study are available from the corresponding author, [KAD], upon reasonable request.

Source: Haemophilia

DOI: 10.1111/hae.70273

Authors: Kyle Davis, Amy Shapiro, Sanjay Ahuja

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Roche, Genentech

OpenAlex ID: W7141110690

FWCI:

Cites: 8

Cited by:

Related to: